Clinical Data Soars on Viibryd Depression Nod, Sale Talk
By Jennifer Boggs
Tuesday, January 25, 2011
Shares of Clinical Data Inc. skyrocketed 67.5 percent Monday after the FDA's late Friday approval of vilazodone in major depressive disorder quieted skeptics and positioned the Newton, Mass.-based firm as a potential takeover target.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.